alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Here's how you know
 **Official websites use .mil** .mil
 **Secure .mil websites use HTTPS** lock () https://


Skip to main content (Press Enter).
 Toggle navigation
                
                Defense Logistics Agency
                        The Nation's Combat Logistics Support Agency
                    DLA
            Search
                        Search Defense Logistics Agency:
                            Search
                    Search Defense Logistics Agency:
                        Search
    Home

    What DLA Offers
    
        Excess Property Disposal

    Document Services

    Products

    Services

    Programs

    Working With DLA
    
        Applications

    Small Business

    Federal and International Cataloging

    Defense Data Standards

    Events

    Procurement Policies

    Government Programs

    Forms

    Organizations
    
        DLA Headquarters

    DLA Aviation

    DLA Disposition Services

    DLA Distribution

    DLA Energy

    DLA Land and Maritime

    DLA Troop Support

    DLA CENTCOM & SOCOM

    DLA Europe & Africa

    DLA Indo-Pacific

    Customer Support
    
        Self Help Tools

    How to Order

    Find Your Order

    Customer Facing Offices

    Training

    Brochures

    Warfighter Support

    Customer Service Management

    Careers

    About DLA
    
        Contact Us

    Locations

    Leaders

    News

    History

    Media Gallery

    DLA Campaigns  Home
  Land and Maritime
  About
  DLA Land and Maritime Image Galleries
 DLA Land and Maritime images
 Supply Chain Alliance and Exhibition
 DLA Land and Maritime News
 Hall of Fame Ceremonies
 DSCC Activities
 DLA Land and Maritime Hall of Fame ceremonies
 Search
 Search
 All Images All ImagesOther
 Upload Date Upload DatePhoto DateTitle
  Clear Search
 2024 DLA Supply Chain Alliance Conference and Exhibition Image Gallery
 Search
 Search
 All Images All ImagesOther
 Upload Date Upload DatePhoto DateTitle
  Clear Search
 
  FIRST

        

        

        
        10
        
        11
        
        12
        
        13
        
        14 (current)
        

        


        


        LAST
 DLA Land and Maritime news
 Search
 Search
 All Images All ImagesOther
 Upload Date Upload DatePhoto DateTitle
  Clear Search
 
  FIRST

        

        

        
        12
        
        13
        
        14 (current)
        
        15
        
        16
        

        


        


        LAST
 DSCC activities
 Search
 Search
 All Images All ImagesOther
 Upload Date Upload DatePhoto DateTitle
  Clear Search
 Contact UsSite IndexStrategic PlanDLA IG HotlineFOIANo FEAR ActWhistleblower ProtectionDLA CareersImagesWebmasterEEOSection 508Public AffairsSAPRExternal Links DisclaimerDOD Information Quality GuidelinesPrivacy/SecurityUSA.govDOD Web PolicyDOD Open GovernmentPlain Language
                    Stay Connected
            
            

Hosted by Defense Media Activity - WEB.mil
June 12, 2014




Mr. Joseph M. Harary
c/o Research Frontiers
Inc.
240
Crossways Park Drive
Woodbury, NY 11797-2033

Dear Mr. Harary:

This letter agreement sets forth the  terms of the
amendment to the employment agreement between
you and Research Frontiers Inc.  dated as of January 1, 2009 (the “Employment
Agreement”).

As previously authorized by the  Compensation Committee
of the Board of Directors of Research
Frontiers Inc., effective  January 1, 2014 your annual Base Salary under Section 4(a) of the
Employment Agreement shall be  $450,000.

Effective as of June 12, 2014 all  references to “December
31, 2013” in the Employment Agreement
shall be replaced with a  reference to “December 31, 2019”.

All other terms of the Employment  Agreement shall remain in
effect. If this accurately reflects our
agreement, please sign  where indicated below.

	 	Sincerely,
		 
	 	/s/ Robert L. Saxe
		
      Robert L. Saxe
Chairman of the Board of
      Directors




AGREED:

	/s/ Joseph M. Harary
	Joseph M. Harary
## NO. 12

- 20

- 00262

- CV

IN THE COURT OF APPEALS

TWELFTH COURT OF APPEALS DISTRICT

TYLER, TEXAS

EAST TEXAS KIDNEY S P

ECIALISTS, P.A., RAJIV VIJ M.D., P.A. AND WALGREEN CO. , APPELLANT S

V.

STEVEN GARRISON , APPELLEE §

§

§ APPEAL FROM THE

COUNTY COURT AT LAW NO

. 2

GREGG COUNTY, TEXAS

MEMORANDUM OPINION PER CURIAM

A ppellant s, East Texas Kidney Specialists, P.A., and Rajiv Vij, M.D., P. A
., filed a motion to dismiss this appeal. No decision has been delivered in this appeal. Accordingly, Appell ant s ’ mo tion to dismiss is granted, and the appeal is dismissed AS TO East Texas Kidney Specialists, P.A. and Rajiv Vij M.D., P.A

. See T EX

. R. A PP

. P

. 42. 1 (a) (1)

. All costs are taxed against the party incurring same. This dismissal does not affect the appeal fi led by Walgreen Co. Opinion delivered December 22 , 2020. Panel consisted of Worthen, C.J., Hoyle, J., and Neeley, J.

## CO URT OF APPEALS

TWELFTH COURT OF APPEALS DISTRICT OF TEXAS

JUDGM ENT

DECEMBER 22 , 2 020

NO. 12

- 20

- 00262

- CV

E AST TEXAS KIDNEY SPE CIALISTS, P.A., RAJIV VIJ M.D., P.A. AND WALGREEN CO. , Appellant s V. STEVEN GARRISON , Appellee

Appeal from the County Cour t at Law No

. 2

of Gregg County, Texas (Tr.Ct.No. 2020

- 761

- CCL2 )

T HIS CAUSE came on to be heard on the motion of the Appellant s East Texas Kidney Specialists, P.A., and Rajiv Vij, M.D., P. A
., to dismiss the appeal herein, and the same being considered, it is hereby ORDERED, ADJUDGED and DECREED by this Court that the m otion

to dismiss be granted and the appeal be dismissed as to East Te xas Kidney Specialists, P.A.,

and Rajiv Vij, M.D., P. A
., and that the decision be certif ied to the court below fo r observance.

All costs are taxed against the party incurring same. This dismissal does not affect the appeal filed by Walgreen Co.
By per cur iam opinion

. Panel consisted of Worthen, C.J., Hoyle, J. and Neel ey, J.
No. 10-7827.

#### Erica Bishop, Petitioner v. Housing Authority of South Bend.

562 U.S. 1189, 131 S. Ct. 1022,

178 L. Ed. 2d 846,

2011 U.S. LEXIS 865.

January 18, 2011.

Petition for writ of certiorari to the Court of Appeals of Indiana, Third District, denied.

Same case below, 920 N.E.2d 772.
In The

Court of Appeals

Sixth Appellate District of Texas at Texarkana

No. 06-16-00164-CR

TIMOTHY LEON LUECK, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 336th District Court

Fannin County, Texas

Trial Court No. 15-25575

Before Morriss, C.J., Moseley and Burgess, JJ.
2

O R D E R

Court reporter Charla Reamy recorded the trial court proceedings in appellate cause 

number 06-16-00164-CR, styled Timothy Leon Lueck v. The State of Texas, trial court cause 

number 15-25575 in the 336th Judicial District Court of Fannin County, Texas. A copy of this 

record has been requested by a family member of Timothy Leon Lueck. 

Prior to releasing certain portions of the reporter’s record, we asked Reamy to redact 

sensitive data from those portions of the record. See TEX. R. APP. P. 9.10. Reamy has respectfully 

declined to redact the sensitive data as we requested. Sensitive data includes,

(1) A driver’s license number, passport number, social security number, tax 

identification number or similar government-issued personal identification number;

(2) bank account number, credit card number, and other financial account 

number;

(3) a birth date, a home address, and the name of any person who was a minor 

at the time the offense was committed.

TEX. R. APP. 9.10(a). Rule 9.10(b) states, “Unless a court orders otherwise, an electronic or paper 

filing with the court, including the contents of any appendices, must not contain sensitive data.” 

Further, “[t]he filing of a document constitutes a certification by the filer that the document 

complies with paragraphs (a) and (b) of this rule.” TEX. R. APP. P. 9.10(e). 

Having determined that volume seven of the reporter’s record contains sensitive data, as 

that term is defined by Rule 9.10, we hereby ORDER Reamy to redact volume seven of any and 

all sensitive data included on pages 1–63 of that record.1

 

1Although the remaining portions of volume seven and volume eight likewise include sensitive data, Reamy need not 

redact those portions of the record as they are, by statute, confidential and not subject to release.
3

The redacted reporter’s record is to be received by this Court no later than Wednesday, 

March 14. If the redacted reporter’s record is not received by March 14, we warn Reamy that we 

may begin contempt proceedings and order her to show cause why she should not be held in 

contempt of this Court for failing to obey its order.

IT IS SO ORDERED.

BY THE COURT

Date: February 21, 2018
Video: Cómo usar un inhalador oral de nicotina

AUDIO: Música sin letra reproduciéndose hasta el final del video.

TARJETA DE TÍTULO - TEXTO EN PANTALLA: 

Cómo usar un inhalador oral de nicotina

El inhalador oral de nicotina está disponible solo con receta médica. 

TEXTO DESCRIPTIVO: El texto del título está en un cuadrado. En el fondo hay una animación con 

inhaladores orales y puntos de colores que se cruzan en forma diagonal detrás del cuadrado de texto. 

TEXTO EN PANTALLA: Comience a usar el inhalador oral en la fecha en que va a dejar de fumar.

TEXTO DESCRIPTIVO: La fecha para dejar de fumar aparece dentro de un círculo en un calendario.

TEXTO EN PANTALLA: Úselo según las indicaciones de su proveedor de atención médica

TEXTO DESCRIPTIVO: Se muestra un médico sosteniendo un inhalador oral.

TEXTO EN PANTALLA: y las instrucciones del envase. 

TEXTO DESCRIPTIVO: Entran en la escena en forma de animación un inhalador, una caja e 

instrucciones. 

TEXTO EN PANTALLA: Inhale de manera corta, poco profunda y frecuente 

TEXTO DESCRIPTIVO: Una mano sosteniendo un inhalador entra en la escena. 

TEXTO EN PANTALLA: para absorber la nicotina a través de la boca y la garganta. 

TEXTO DESCRIPTIVO: Una persona se pone el inhalador en la boca y toma tres inhalaciones con la 

boca cerrada. 

TEXTO EN PANTALLA: No inhale el medicamento hasta lo más profundo de sus pulmones. 

TEXTO DESCRIPTIVO: La medicina entra en la garganta. 
TEXTO EN PANTALLA: No coma ni beba mientras usa el inhalador o durante un periodo de 15 minutos

antes de usarlo. 

TEXTO DESCRIPTIVO: Varios alimentos, bebidas y cubiertos conforman un gráfico de fondo. 

TEXTO EN PANTALLA: El uso correcto lo ayudará a evitar efectos secundarios...

TEXTO DESCRIPTIVO: Fondo sólido.

TEXTO EN PANTALLA: y a mantenerse sin fumar.

TEXTO DESCRIPTIVO: Un brazo con la mano en un gesto de “pulgar hacia arriba” entra en la escena.

TEXTO EN PANTALLA: 

Hable con su proveedor de atención médica para obtener ayuda con el uso de medicamentos para dejar

de fumar.

Para obtener más ayuda para dejar de fumar, llame al 1-855-DÉJELO-YA 

TEXTO DESCRIPTIVO: El texto está en un cuadrado. En el fondo hay una animación con inhaladores 

orales y puntos de colores que se cruzan en forma diagonal detrás del cuadrado de texto. 

TEXTO EN PANTALLA: 

Este video es parte de una colaboración con la Iniciativa Smokefree.gov del Instituto Nacional del

Cáncer.

Los CDC no respaldan a ninguna organización, producto o servicio en particular. 

TEXTO DESCRIPTIVO: Logotipos conjuntos del Departamento de Salud y Servicios Humanos de los EE. 

UU. y los Centros para el Control y la Prevención de Enfermedades.
I 

116TH CONGRESS 

1ST SESSION H. R. 2680 

To amend section 330C of the Public Health Service Act to reauthorize 

special programs for Indians for providing services for the prevention 

and treatment of diabetes, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 10, 2019 

Mr. O’HALLERAN (for himself, Mr. COLE, Ms. HAALAND, Ms. DEGETTE, Mr. 

REED, and Mr. MULLIN) introduced the following bill; which was referred 

to the Committee on Energy and Commerce 

A BILL 

To amend section 330C of the Public Health Service Act 

to reauthorize special programs for Indians for providing 

services for the prevention and treatment of diabetes, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Special Diabetes Pro5 grams for Indians Reauthorization Act of 2019’’. 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 2680 IH

1 SEC. 2. REAUTHORIZATION OF SPECIAL DIABETES PRO2 GRAMS FOR INDIANS FOR DIABETES SERV3 ICES. 

4 Section 330C(c)(2)(D) of the Public Health Service 

5 Act (42 U.S.C. 254c–3(c)(2)(D)) is amended after 

6 ‘‘$150,000,000 for each of fiscal years 2018 and 2019’’ 

7 by inserting ‘‘and $200,000,000 for each of fiscal years 

8 2020 through 2024’’. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
# C_2013359EN.01002002.xml

| 7.12.2013 | EN | Official Journal of the European Union | C 359/20 |
| --- | --- | --- | --- |

7.12.2013

EN

Official Journal of the European Union

C 359/20

---

Order of the General Court of 10 October 2013 — KO-Invest v OHIM — Kraft Foods Schweiz (Milkoshake For Active People)

(Case T-399/13) (1)

1

2013/C 359/38

Language of the case: Polish

The President of the Sixth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 284, 28.9.2013.

1

---
**Exhibit
          32.1**
  **CERTIFICATIONS
          PURSUANT TO**
 SECTION
          906 OF THE SARBANES-OXLEY ACT OF 2002
 (18
          U.S.C. SECTION 1350)
 
 In
          connection with the Quarterly Report of Able Energy Inc. (the "Company"),
          on
          Form 10-Q for the quarter ended September 30, 2006, as filed with the Securities
          and Exchange Commission (the "Report"), Gregory D. Frost, Chief Executive
          Officer of the Company and Jeffery Feld, Acting Chief Financial Officer
          of the
          Company, do each hereby certify, pursuant to ss. 906 of the Sarbanes-Oxley
          Act
          of 2002 (18 U.S.C. ss. 1350), that to his knowledge:
 
 (1)
          The
          Report fully complies with the requirements of section 13(a) or 15(d) of
          the
          Securities Exchange Act of 1934; and
 
 (2)
          The
          information contained in the Report fairly presents, in all material respects,
          the financial condition and result of operations of the Company.
  */s/
                      Gregory Frost**Gregory
                    D.
                    Frost**Chief
                    Executive Officer**July
                    23 ,
                    2007**/s/
                    Jeffery Feld**Jeffery
                    Feld**Acting
                    Chief
                    Financial Officer**July
                      23, 2007*
 [A
          signed
          original of this written statement required by Section 906 has been provided
          to
          Able Energy Inc. and will be retained by Able Energy Inc. and furnished
          to the
          Securities and Exchange Commission or its staff upon request.]
Tampoco

pensaba que 

fumaba tanto.

Christine, 55 años, Pensilvania 

Diagnosticada de cáncer a los 44 años

Christine comía alimentos saludables. Hacía 

ejercicio. Se sentía sana. No pensaba 

que la cantidad que fumaba le haría daño. 

Pero, a los 44 años, le diagnosticaron 

cáncer oral. Y le volvió dos veces. 

Hoy en día tiene solamente la mitad de su 

mandíbula y ningún diente.

Usted puede dejar de fumar. 

Para recibir ayuda gratuita, llame al

1-855-DÉJELO-YA.

Christine, a los 39 años

#CDCConsejos

Solamente impreso
United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

No. 10-3017 September Term, 2011

UNITED STATES OF AMERICA,

APPELLEE

v.

JESUS RODRIGUEZ,

APPELLANT

Appeal from the United States District Court

for the District of Columbia

(No. 1:08-cr-00344-1)

Before: HENDERSON, Circuit Judge, and WILLIAMS and GINSBURG, Senior Circuit Judges.

SEALED OPINION NOT AVAILABLE TO THE

PUBLIC
No. 09-1343.

#### J. McIntyre Machinery, Ltd., Petitioner v. Robert Nicastro, et ux.

562 U.S. 1198, 131 S. Ct. 1061,

178 L. Ed. 2d 861,

2011 U.S. LEXIS 999.

January 24, 2011.

Motion of respondent Robert Nicastro, the authorized representative of the Estate of Roseanne Nicastro, to be substituted as party for Roseanne Nicastro granted.
No. 10-5258.

#### Clifton Terelle McNeill, Petitioner v. United States.

562 U.S. 1128, 131 S. Ct. 856,

178 L. Ed. 2d 623,

2011 U.S. LEXIS 15.

January 7, 2011.

Motion of petitioner for leave to proceed in forma pauperis granted. Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit granted.

Same case below, 598 F.3d 161.
# C_2013207EN.01005801.xml

| 20.7.2013 | EN | Official Journal of the European Union | C 207/58 |
| --- | --- | --- | --- |

20.7.2013

EN

Official Journal of the European Union

C 207/58

---

Action brought on 8 April 2013 — ZZ v Commission

(Case F-32/13)

2013/C 207/96

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: F. Moyse, lawyer)

Applicant:

Defendant: European Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Annulment of the rejection of the application for reimbursement of the unpaid sum which the Commission ought to pay to the applicant as the severance grant.

Form of order sought

Form of order sought

| — | Annul the Commission’s decision of 9 January 2013 by which it refused to grant the applicant’s application and rejected his complaint seeking to obtain reimbursement of the unpaid sum which the Commission ought to pay him because he resigned. To the extent necessary, the action also seeks annulment of the Commission’s letter of 13 April 2012 by which the Commission adopts a view for the first time relating to the applicant’s application to recalculate the amount which the Commission must pay to him; |
| --- | --- |

—

Annul the Commission’s decision of 9 January 2013 by which it refused to grant the applicant’s application and rejected his complaint seeking to obtain reimbursement of the unpaid sum which the Commission ought to pay him because he resigned. To the extent necessary, the action also seeks annulment of the Commission’s letter of 13 April 2012 by which the Commission adopts a view for the first time relating to the applicant’s application to recalculate the amount which the Commission must pay to him;

| — | order the Commission to pay the costs. |
| --- | --- |

—

order the Commission to pay the costs.

---
No. 10-7610.

#### Albert M. Cole, Petitioner v. United States.

562 U.S. 1156, 131 S. Ct. 953,

2011 U.S. LEXIS 297.

178 L. Ed. 2d 786,

January 10, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.

Same case below, 614 F.3d 726.
Final - April 18, 2023 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) 

Centers for Disease Control and Prevention 

Atlanta, Georgia 30329 

April 19, 2023 

AGENDA ITEM 

Wednesday, April 19, 2023 

PRESIDER/PRESENTER(s) 

11:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair) 

Dr. Melinda Wharton (ACIP Executive Secretary, CDC) 

11:10 Coronavirus Disease 2019 (COVID-19) Vaccines 

Introduction 

COVID-19 vaccine program updates 

COVID-19 vaccine safety updates 

Update: v-safe after vaccination health checker 

COVID-19 vaccine effectiveness updates 

Updates to COVID-19 vaccine policy: data and work 

group considerations 

Clinical considerations updates 

Dr. Matthew Daley (ACIP, WG Chair) 

Dr. Georgina Peacock (CDC/NCIRD) 

Dr. Tom Shimabukuro (CDC/NCEZID) 

Dr. Tom Shimabukuro (CDC/NCEZID) 

Dr. Ruth Link-Gelles (CDC/NCIRD) 

Dr. Sara Oliver (CDC/NCIRD) 

Dr. Evelyn Twentyman (CDC/NCIRD) 

1:15 Break

1:30 Public Comment 

1:50 Committee discussion 

3:00 Adjourn 

Acronyms

CDC Centers for Disease Control and Prevention 

CMS Centers for Medicare and Medicaid Services 

COVID-19 Coronavirus disease 2019 

EtR Evidence to Recommendations Framework 

FDA Food and Drug Administration 

GRADE Grading of Recommendations Assessment, Development and Evaluation 

HRSA Health Resources and Services Administration 

IHS Indian Health Service 

NCHHSTP National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/DDID] 

NCIRD National Center for Immunization & Respiratory Diseases [of CDC/DDID] 

NCEZID National Center for Emerging and Zoonotic Diseases [of CDC/DDID] 

NIAID National Institute of Allergy and Infectious Diseases 

OIDP Office of Infectious Disease and HIV/AIDS Policy 

SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 

WG Work Group 

WHO World Health Organization 

VaST COVID-19 Vaccine Safety Technical (VaST) Work Group 

VE Vaccine Effectiveness
[Federal Register Volume 63, Number 129 (Tuesday, July 7, 1998)]
[Notices]
[Page 36676]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17894]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket No. GT98-67-000]


Tennessee Gas Pipeline Company; Notice of Refund Report

June 30, 1998.
    Take notice that on June 26, 1998, Tennessee Gas Pipeline Company 
(Tennessee) tendered for filing a refund report pursuant to Ordering 
Paragraph (c) of the Commission's February 22, 1995, order in Gas 
Research Institute (GRI), Docket No. RP95-124-000.
    Tennessee states that Tennessee received a refund from GRI in the 
amount of $1,170,085.
    Tennessee states that it has refunded these amounts to its firm 
transportation customers that received nondiscounted service during 
1997 by adjustmenting their June invoices.
    Tennessee states that copies of this filing have been mailed to 
each of Tennessee's customers and interested state commissions.
    Any person desiring to be heard or to protest this filing should 
file a motion to intervene or a protest with the Federal Energy 
Regulatory Commission, 888 First Street, N.E., Washington, D.C. 20426, 
in accordance with Sections 385.214 and 385.211 of the Commission's 
Rules and Regulations. All such motions or protests must be filed on or 
before July 7, 1998. Protests will be considered by the Commission in 
determining the appropriate action to be taken, but will not serve to 
make protestants parties to the proceedings. Any person wishing to 
become a party must file a motion to intervene. Copies of this filing 
are on file with the Commission and are available for public inspection 
in the Public Reference Room.
David P. Boergers,
Acting Secretary.
[FR Doc. 98-17894 Filed 7-6-98; 8:45 am]
BILLING CODE 6717-01-M
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY

2000 TRAVERWOOD DRIVE

ANN ARBOR, MI 48105-2498

 OFFICE OF

AIR AND RADIATION

May 7, 2012

MEMORANDUM

SUBJECT: Jaguar Land Rover Meetings with EPA Regarding Proposal for 2017-2025 LightDuty (LD) Greenhouse Gas (GHG) Standards

FROM: Robin Moran, Senior Policy Advisor

TO: EPA Docket # EPA-HQ-OAR-2010-0799

This memo documents meetings held on January 18, January 20, and February 6, 2012 between 

representatives of Jaguar Land Rover (JLR) and EPA to discuss JLR’s comments on the LD 

GHG proposed rule. The meeting attendees included the following:

JLR: Derrick Weil, Clinton Blair, David Kelley

EPA: Chet France, Bill Charmley, Robin Moran, and Margo Oge (January 20 meeting only)

The topics included JLR’s plans to achieve the 2017-2025 proposed standards, challenges they 

foresee with leadtime in the early years of the program, and suggested concepts for additional 

leadtime for niche, limited line, manufacturers. During the January 18, 2012 meeting, JLR 

provided confidential business information regarding its future product plans and challenges in 

meeting the standards.